3 results match your criteria: "Ottawa Hospital Regional Cancer Program[Affiliation]"
Radiol Case Rep
November 2024
The Ottawa Hospital Cancer Centre, Ottawa Hospital Regional Cancer Program, Ottawa, Canada.
Intraosseous meningiomas are a rare subtype of meningiomas representing approximately 2% of all cases. They can confound a diagnosis of other bone lesions including metastatic tumors. We present a case of a patient with prostate cancer who on staging workup was suspected to have a skull metastasis.
View Article and Find Full Text PDFWorld J Urol
January 2024
Ottawa Hospital Cancer Centre, Ottawa Hospital Regional Cancer Program, Ottawa, Canada.
Renal cell carcinoma (RCC) is an uncommon malignancy whose incidence has been increasing over the past few decades, posing treatment challenges for elderly or infirm patients who are not surgical candidates. Stereotactic ablative radiotherapy (SABR) has emerged as a promising non-invasive treatment modality for RCC. The high dose-per-fraction used in SABR overcomes some of the mechanisms of radioresistance that has hindered the effective treatment of RCC with conventional radiotherapy.
View Article and Find Full Text PDFCan Urol Assoc J
July 2014
Medical Oncologist, Regional Cancer Center, Medical Lead, Breast Disease Site, Head Survivorship Program, Associate Professor of Medicine, University of Ottawa, The Ottawa Hospital Regional Cancer Program, Ottawa, ON.
Men who undergo long-term androgen deprivation therapy (ADT) may experience systemic side effects similar to the classical metabolic syndrome. Exercise is a potential strategy for offsetting the adverse effects of ADT among patients with prostate cancer, resulting in improved muscular resistance and positive outcomes on body size and composition. Fitness (aerobic capacity), fatigue and certain quality of life (QOL) outcomes may also improve in response to a regular exercise regimen.
View Article and Find Full Text PDF